000			01804cam a2200433 a 4500
001			748675182
003			MACHS
005			20230122145246.0
008			110826s2013 paua b 001 0 eng
010			_a2011036313
016	7		_a101567997 _2DNLM
016	7		_a016035677 _2Uk
020			_a9781609133450
020			_a1609133455
020			_a9781451175721 (International ed.) _c241.5 SAR
020			_a1451175728 (International ed.)
035			_a.b70877312
040			_aDNLM/DLC _beng _cDLC _dYDX _dNLM _dQBA _dYDXCP _dVET _dOCLCO _dBTCTA _dCDX _dY8N _dUKMGB _dU9X _dOCLCF _dP4I _dOSU _dUtOrBLW
042			_apcc
049			_aOSUU
050		4	_aRS403 _b.P75 2013
050		4	_aRS403 _b.P75 2013
100			_aFoye, William O
245	0	0	_aFoye's principles of medicinal chemistry /
246	3	0	_aPrinciples of medicinal chemistry
250			_a7th ed
260			_aPhiladelphia : _bWolters Kluwer Health/Lippincott Williams & Wilkins, _cc2013
300			_axviii, 1,500 p. : _bill. ; _c29 cm
504			_aIncludes bibliographical references and indexes
505	0		_aPrinciples of drug discovery -- Drug receptors affecting neurotransmission and enzymes as catalytic receptors -- Pharmacodynamic agents -- Disease state management
520	8		_aThis edition places emphasis on patient-focused pharmaceutical care and on the pharmacist as a therapeutic consultant, rather than a chemist. A new disease state management section explains appropriate therapeutic options for asthma, chronic obstructive pulmonary disease, and men's and women's health problems
650		0	_aPharmaceutical chemistry
650		0	_aPharmacology
650	1	2	_aChemistry, Pharmaceutical
700	1		_aFoye, William O
700	1		_aLemke, Thomas L
700	1		_aWilliams, David A., _d1938-
942			_2lcc _cBK
999			_c674 _d674